Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Next generation sequencing panel in undifferentiated autoinflammatory diseases identifies patients with colchicine-responder recurrent fevers.

Papa R, Rusmini M, Volpi S, Caorsi R, Picco P, Grossi A, Caroli F, Bovis F, Musso V, Obici L, Castana C, Ravelli A, Van Gijn ME, Ceccherini I, Gattorno M.

Rheumatology (Oxford). 2019 Aug 13. pii: kez376. doi: 10.1093/rheumatology/kez376. [Epub ahead of print] No abstract available.

PMID:
31410474
2.

Next generation sequencing panel in undifferentiated autoinflammatory diseases identifies patients with colchicine-responder recurrent fevers

Papa R, Rusmini M, Volpi S, Caorsi R, Picco P, Grossi A, Caroli F, Bovis F, Musso V, Obici L, Castana C, Ravelli A, Van Gijn ME, Ceccherini I, Gattorno M.

Rheumatology (Oxford). 2019 Jul 19. pii: kez270. doi: 10.1093/rheumatology/kez270. [Epub ahead of print]

PMID:
31325311
3.

Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis.

Minoia F, Bovis F, Davì S, Horne A, Fischbach M, Frosch M, Huber A, Jelusic M, Sawhney S, McCurdy DK, Silva CA, Rigante D, Unsal E, Ruperto N, Martini A, Cron RQ, Ravelli A; Pediatric Rheumatology International Trials Organization, the Childhood Arthritis & Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group and the Histiocyte Society.

Ann Rheum Dis. 2019 Oct;78(10):1357-1362. doi: 10.1136/annrheumdis-2019-215211. Epub 2019 Jul 11.

PMID:
31296501
4.

Defining responders to therapies by a statistical modeling approach applied to randomized clinical trial data.

Bovis F, Carmisciano L, Signori A, Pardini M, Steinerman JR, Li T, Tansy AP, Sormani MP.

BMC Med. 2019 Jun 18;17(1):113. doi: 10.1186/s12916-019-1345-2.

5.

Non-invasive mitochondrial DNA quantification on day 3 predicts blastocyst development: a prospective, blinded, multi-centric study.

Stigliani S, Orlando G, Massarotti C, Casciano I, Bovis F, Anserini P, Ubaldi FM, Remorgida V, Rienzi L, Scaruffi P.

Mol Hum Reprod. 2019 Jun 7. pii: gaz032. doi: 10.1093/molehr/gaz032. [Epub ahead of print]

PMID:
31174207
6.

A proof-of-concept application of a novel scoring approach for personalized medicine in multiple sclerosis.

Pellegrini F, Copetti M, Bovis F, Cheng D, Hyde R, de Moor C, Kieseier BC, Sormani MP.

Mult Scler. 2019 May 30:1352458519849513. doi: 10.1177/1352458519849513. [Epub ahead of print]

PMID:
31144577
7.

Classification criteria for autoinflammatory recurrent fevers.

Gattorno M, Hofer M, Federici S, Vanoni F, Bovis F, Aksentijevich I, Anton J, Arostegui JI, Barron K, Ben-Cherit E, Brogan PA, Cantarini L, Ceccherini I, De Benedetti F, Dedeoglu F, Demirkaya E, Frenkel J, Goldbach-Mansky R, Gul A, Hentgen V, Hoffman H, Kallinich T, Kone-Paut I, Kuemmerle-Deschner J, Lachmann HJ, Laxer RM, Livneh A, Obici L, Ozen S, Rowczenio D, Russo R, Shinar Y, Simon A, Toplak N, Touitou I, Uziel Y, van Gijn M, Foell D, Garassino C, Kastner D, Martini A, Sormani MP, Ruperto N; Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO).

Ann Rheum Dis. 2019 Aug;78(8):1025-1032. doi: 10.1136/annrheumdis-2019-215048. Epub 2019 Apr 24. Review.

PMID:
31018962
8.

Bloodstream infections in patients living with HIV in the modern cART era.

Taramasso L, Liggieri F, Cenderello G, Bovis F, Giannini B, Mesini A, Giacomini M, Cassola G, Viscoli C, Di Biagio A.

Sci Rep. 2019 Apr 1;9(1):5418. doi: 10.1038/s41598-019-41829-3.

9.

Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study.

Consolaro A, Giancane G, Alongi A, van Dijkhuizen EHP, Aggarwal A, Al-Mayouf SM, Bovis F, De Inocencio J, Demirkaya E, Flato B, Foell D, Garay SM, Lazăr C, Lovell DJ, Montobbio C, Miettunen P, Mihaylova D, Nielsen S, Orban I, Rumba-Rozenfelde I, Magalhães CS, Shafaie N, Susic G, Trachana M, Wulffraat N, Pistorio A, Martini A, Ruperto N, Ravelli A; Paediatric Rheumatology International Trials Organisation.

Lancet Child Adolesc Health. 2019 Apr;3(4):255-263. doi: 10.1016/S2352-4642(19)30027-6. Epub 2019 Feb 26.

PMID:
30819662
10.

Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositis.

Rosina S, Consolaro A, van Dijkhuizen P, Pistorio A, Varnier GC, Bovis F, Nistala K, Maillard S, Civino A, Tsitsami E, de Inocencio J, Jelusic M, Vojinovic J, Espada G, Makay B, Katsicas MM, Pratsidou-Gertsi P, Lazarevic D, Rao AP, Pires Marafon D, Martini A, Pilkington C, Ruperto N, Ravelli A.

Rheumatology (Oxford). 2019 Jul 1;58(7):1196-1205. doi: 10.1093/rheumatology/key421.

PMID:
30690571
11.

Revised upper limb module for spinal muscular atrophy: 12 month changes.

Pera MC, Coratti G, Mazzone ES, Montes J, Scoto M, De Sanctis R, Main M, Mayhew A, Muni Lofra R, Dunaway Young S, Glanzman AM, Duong T, Pasternak A, Ramsey D, Darras B, Day JW, Finkel RS, De Vivo DC, Sormani MP, Bovis F, Straub V, Muntoni F, Pane M, Mercuri E; iSMAC Consortium Group.

Muscle Nerve. 2019 Apr;59(4):426-430. doi: 10.1002/mus.26419. Epub 2019 Feb 7.

PMID:
30677148
12.

Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries.

Swart J, Giancane G, Horneff G, Magnusson B, Hofer M, Alexeeva Е, Panaviene V, Bader-Meunier B, Anton J, Nielsen S, De Benedetti F, Kamphuis S, Staņēviča V, Tracahana M, Ailioaie LM, Tsitsami E, Klein A, Minden K, Foeldvari I, Haas JP, Klotsche J, Horne AC, Consolaro A, Bovis F, Bagnasco F, Pistorio A, Martini A, Wulffraat N, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO), BiKeR and the board of the Swedish Registry.

Arthritis Res Ther. 2018 Dec 27;20(1):285. doi: 10.1186/s13075-018-1780-z.

13.

Management of acute ischemic stroke, thrombolysis rate, and predictors of clinical outcome.

Bandettini di Poggio M, Finocchi C, Brizzo F, Altomonte F, Bovis F, Mavilio N, Serrati C, Malfatto L, Mancardi G, Balestrino M.

Neurol Sci. 2019 Feb;40(2):319-326. doi: 10.1007/s10072-018-3644-3. Epub 2018 Nov 14.

PMID:
30430315
14.

Correction to: Outpatient erbium:YAG (2940 nm) laser treatment for snoring: a prospective study on 40 patients.

Fini Storchi I, Parker S, Bovis F, Benedicenti S, Amaroli A.

Lasers Med Sci. 2019 Mar;34(2):431. doi: 10.1007/s10103-018-2648-9.

PMID:
30350122
15.

Expanded disability status scale progression assessment heterogeneity in multiple sclerosis according to geographical areas.

Bovis F, Signori A, Carmisciano L, Maietta I, Steinerman JR, Li T, Tansy AP, Sormani MP.

Ann Neurol. 2018 Oct;84(4):621-625. doi: 10.1002/ana.25323. Epub 2018 Oct 4.

PMID:
30179270
16.

Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study.

Saccà F, Lanzillo R, Signori A, Maniscalco GT, Signoriello E, Lo Fermo S, Repice A, Annovazzi P, Baroncini D, Clerico M, Binello E, Cerqua R, Mataluni G, Bonavita S, Lavorgna L, Zarbo IR, Laroni A, Rossi S, Pareja Gutierrez L, La Gioia S, Frigeni B, Barcella V, Frau J, Cocco E, Fenu G, Torri Clerici V, Sartori A, Rasia S, Cordioli C, Di Sapio A, Pontecorvo S, Grasso R, Barrilà C, Russo CV, Esposito S, Ippolito D, Bovis F, Gallo F, Sormani MP.

Mult Scler. 2019 Aug;25(9):1263-1272. doi: 10.1177/1352458518790390. Epub 2018 Jul 25.

PMID:
30044207
17.

Haploidentical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission Tomography.

Marani C, Raiola AM, Morbelli S, Dominietto A, Ferrarazzo G, Avenoso D, Giannoni L, Varaldo R, Gualandi F, Grazia D, Lamparelli T, Bregante S, Van Lint MT, Ibatici A, Bovis F, Lemoli RM, Gobbi M, Bacigalupo A, Angelucci E.

Biol Blood Marrow Transplant. 2018 Dec;24(12):2501-2508. doi: 10.1016/j.bbmt.2018.07.025. Epub 2018 Jul 21.

PMID:
30041010
18.

Correction to: The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Consolaro A, Bovis F, Pistorio A, Cimaz R, De Benedetti F, Miniaci A, Corona F, Gerloni V, Martino S, Pastore S, Barone P, Pieropan S, Cortis E, Podda RA, Gallizzi R, Civino A, La Torre F, Rigante D, Consolini R, Maggio MC, Magni-Manzoni S, Perfetti F, Filocamo G, Toppino C, Licciardi F, Garrone M, Scala S, Patrone E, Tonelli M, Tani D, Ravelli A, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Jul;38(7):1311-1313. doi: 10.1007/s00296-018-4042-0.

PMID:
29786780
19.

The Colombian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Malagon C, Mosquera Pongutà AC, De Inocencio J, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):107-113. doi: 10.1007/s00296-018-3941-4. Epub 2018 Apr 7.

20.

The Georgian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Ioseliani M, Pagava K, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):203-209. doi: 10.1007/s00296-018-3952-1. Epub 2018 Apr 7.

21.

The Paraguayan Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Morel Ayala Z, Burgos-Vargas R, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):307-313. doi: 10.1007/s00296-018-3964-x. Epub 2018 Apr 7.

22.

The Russian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Nikishina I, Alexeeva E, Arsenyeva S, Salugina S, Kaleda M, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):339-346. doi: 10.1007/s00296-018-3978-4. Epub 2018 Apr 7.

23.

The Chilean Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Norambuena X, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):99-105. doi: 10.1007/s00296-018-3943-2. Epub 2018 Apr 7.

24.

The Omani Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Al-Abrawi S, Al-Mayouf SM, Abdwani R, Abdalla EIAA, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):299-306. doi: 10.1007/s00296-018-3965-9. Epub 2018 Apr 7.

25.

The Farsi version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Shafaie N, Ziaee V, Aghighi Y, Raees Karami SR, Moradinejad MH, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):171-178. doi: 10.1007/s00296-018-3958-8. Epub 2018 Apr 7.

26.

The Ecuadorian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Mora CH, Garay SM, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):147-153. doi: 10.1007/s00296-018-3947-y. Epub 2018 Apr 7.

27.

The Portuguese version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Melo-Gomes JA, Oliveira-Ramos F, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):323-329. doi: 10.1007/s00296-018-3967-7. Epub 2018 Apr 7.

28.

The Estonian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Pruunsild C, Ilisson J, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):163-169. doi: 10.1007/s00296-018-3948-x. Epub 2018 Apr 7.

29.

The Flemish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Dehoorne J, Joos R, Wouters C, Swart JF, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):187-194. doi: 10.1007/s00296-018-3935-2. Epub 2018 Apr 7.

30.

The Slovak version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Vargová V, Dallos T, Leščišinová M, Mrážik P, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):355-361. doi: 10.1007/s00296-018-3973-9. Epub 2018 Apr 7.

31.

The Thai version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Vilaiyuk S, Soponkanaporn S, Lerkvaleekul B, Pipatkullachart T, Mairiang D, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):387-393. doi: 10.1007/s00296-018-3977-5. Epub 2018 Apr 7.

32.

The Algerian Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Aiche MF, Djoudi H, Al-Mayouf S, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):27-33. doi: 10.1007/s00296-018-3937-0. Epub 2018 Apr 7.

33.

The Polish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Rutkowska-Sak L, Smolewska E, Zygmunt A, Kwiatkowska M, Gazda A, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):315-321. doi: 10.1007/s00296-018-3966-8. Epub 2018 Apr 7.

34.

The British English version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Martin N, Davidson J, Anderson C, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):67-73. doi: 10.1007/s00296-018-3985-5. Epub 2018 Apr 7.

35.

The French version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Quartier P, Hofer M, Wouters C, Truong TTT, Duong NP, Agbo-Kpati KP, Uettwiller F, Melki I, Mouy R, Bader-Meunier B, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):195-201. doi: 10.1007/s00296-018-3951-2. Epub 2018 Apr 7.

36.

The Hebrew version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Uziel Y, Sherman G, Rabinowicz N, Harel L, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):227-233. doi: 10.1007/s00296-018-3956-x. Epub 2018 Apr 7.

37.

The Swiss French version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Hofer M, von Scheven-Gête A, Santos M, Quartier P, Wouters C, Vanoni F, Saurenmann RK, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):379-386. doi: 10.1007/s00296-018-3981-9. Epub 2018 Apr 7.

38.

The Lithuanian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Rusoniene S, Panaviene V, Jankauskaitė K, Cvilik D, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):275-282. doi: 10.1007/s00296-018-3970-z. Epub 2018 Apr 7.

39.

The Ukrainian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Boyko Y, Hrytsiuk I, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):403-409. doi: 10.1007/s00296-018-3983-7. Epub 2018 Apr 7.

40.

The Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Al-Mayouf SM, AlE'ed A, Muzaffer M, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organization (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):43-49. doi: 10.1007/s00296-018-3979-3. Epub 2018 Apr 7.

41.

The Czech version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Doležalová P, Bohm M, Linková L, Saifrídová M, Němcová D, Dallos T, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):123-130. doi: 10.1007/s00296-018-3969-5. Epub 2018 Apr 7.

42.

The Brazilian Portuguese version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Fernandes TAP, Magalhães CS, Oliveira SK, Sztajnbok F, de Oliveira Sato J, Darze LS, de Almeida RG, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):59-66. doi: 10.1007/s00296-018-3936-1. Epub 2018 Apr 7.

43.

The Egyptian Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

El Miedany Y, El Mikkawy DME, Youssef SS, El Gaafary M, Nassar N, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):155-161. doi: 10.1007/s00296-018-3949-9. Epub 2018 Apr 7.

44.

The Latvian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Rumba-Rozenfelde I, Saulite I, Rubene A, Razuka-Ebela D, Maija-Butnere M, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):259-265. doi: 10.1007/s00296-018-3959-7. Epub 2018 Apr 7.

45.

The Swedish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Ekelund M, Berntson L, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):371-377. doi: 10.1007/s00296-018-3975-7. Epub 2018 Apr 7.

46.

The Slovene version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Toplak N, Avcin T, Camernik M, Hren M, Sever M, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):363-369. doi: 10.1007/s00296-018-3974-8. Epub 2018 Apr 7.

47.

The Dutch version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Wulffraat N, Kamphuis S, Swart JF, Vastert S, Van Dijkhuizen P, van Pelt P, van Dijk-Hummelman A, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):139-146. doi: 10.1007/s00296-018-3971-y. Epub 2018 Apr 7.

48.

The Serbian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Susic G, Vojinovic J, Vijatov-Djuric G, Stevanovic D, Lazarevic D, Djurovic N, Novakovic D, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):347-354. doi: 10.1007/s00296-018-3972-x. Epub 2018 Apr 7.

49.

The Mexican Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Gutierrez-Suarez R, Burgos-Vargas R, Burgos-Martinez G, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):283-289. doi: 10.1007/s00296-018-3961-0. Epub 2018 Apr 7.

50.

The Hungarian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Orbán I, Constantin T, Dérfalvi B, Sevcic K, Garan D, Káposzta R, Poór G, Kiss E, Ponyi A, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):243-250. doi: 10.1007/s00296-018-3955-y. Epub 2018 Apr 7.

Supplemental Content

Support Center